Companies

See how salaries can vary from company to company

Oncology Rehab is dedicated to setting Standards of Care for oncology rehabilitation across the nation and bringing the field of oncology rehabilitation into collaboration with the greater medical profession. We will continuously keep the focus of our knowledge and our expertise in the development of leading edge oncology-based rehabilitative treatment, and we will remain highly committed to the creation and the advancement of patient care in this specialty management field. This mission is driven by our desire to fulfill our patients' needs to live their lives as normally, as fully, and as ac... view company details

A Head for Profits cleans, services and installs draft beer systems for the food and beverage industry. view company details

What began as the Flying Tomato and five day a week lunch spot serving on paper plates with plastic forks has evolved into a tradition of freshly preparing breads, dressings and desserts each morning as well as serving as a supporter of Knoxville's culture, neighborhoods and people. With food as the focus, The Tomato Head has also served as a venue to musical acts, poetry readings, and performance art. It continues to host monthly exhibits that celebrate local artist efforts. Yes, we are hiring as well as our sister bakery, Flour Head Bakery. We are always looking for talented folks to join ou... view company details

view company details

At the Visiting Nurse Service of New York (VNSNY), our mission is to improve the health and well-being of people through high-quality, cost effective healthcare in the home and community. We've been a vital part of New Yorkers' lives since 1893, with a tradition of vision and action that has taken our industry in new and important directions. On any given day, VNSNY has over 44,300 patients and health plan members in its care. In 2019, we served over 106,000 patients in the five boroughs of New York City, Nassau, Suffolk and Westchester Counties. Our patients range from newborns to the oldest ... view company details

view company details

view company details

view company details

Diablo Valley Oncology provides comprehensive cancer care to patients by bringing together medical oncology, chemotherapy, radiation therapy, PET/CT and diagnostic imaging, research, and supportive care all in one convenient location. The specialized care you receive at Diablo Valley Oncology combines the best in clinical medicine with an outstanding staff and services that meet the individual needs of each patient. Diablo Valley Oncology & Hematology Medical Group (DVO) was voted one of the Top Workplaces by its employees 5 years in a row! 2001-2015 Top Workplaces is a stamp of approval from ... view company details

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The ... view company details

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown antigens. The company develops two immuno-oncology platform technologies, including Sleeping Beauty (SB), which is based on the genetic engineering of immune cells using a non-viral transposon/transposase system to reprogram T-cells outside of the body for infusion; and Controlled IL-12, which delivers interleukin 12 or IL-12, a master regular of the immune system, in a controlled and safe manner to f... view company details

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, the European Union, and internationally. The company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It also provides lucitanib, an oral inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors, platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors. The c... view company details

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidate is Tipifarnib, an oral farnesyl transferase inhibitor that is in Phase II clinical trials for the treatment of solid tumors, peripheral T-cell lymphomas, myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia. It is also developing KO-947, a small molecule inhibitor of extracellular signal related kinase used for the treatment of patient... view company details

view company details

Precision Therapeutics Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries... view company details

view company details

JEFFERSON-CLARION HEAD START, INC. is a company based out of 18 WESTERN AVE STE C, BROOKVILLE, Pennsylvania, United States. view company details

Early Childhood Education program with curriculum for pregnancy through age 5. view company details

Trovagene, Inc., a clinical-stage, oncology therapeutic company, develops drugs to treat various types of cancer, including leukemia, lymphomas, and solid tumors. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic Colorectal Cancer in combination with FOLFIRI and Avastin. The onvansertib is also in Phase II clinical trial in combination with Zytiga fo... view company details

Visiting Nurse is a provider of homecare and hospice services. view company details